Universal API Implementation Guide
1.1.20 - ci-build
Universal API Implementation Guide - Local Development build (v1.1.20) built by the FHIR (HL7® FHIR® Standard) Build Tools. See the Directory of published versions
Tecentriq Hybreza was FDA approved on 9/12/2024. Access Solutions/Patient Foundation enrollments via UAPI were made available on 9/25/2024.
Questionnaires for Access Solutions/Patient Foundation enrollments can be accessed by requesting Tecentriq Hybreza questionnaire definitions from the Genentech FHIR Server.
URL to AS/GPF Questionnaire endpoint (test): https://test-us-e1.apis.roche.com/pharma-cmg-ehr-fhir-exp-test/v2/questionnaire?name=Tecentriq Hybreza
URL to AS/GPF Questionnaire endpoint (stage): https://stage-us-e1.apis.roche.com/pharma-cmg-ehr-fhir-exp-stage/v2/questionnaire?name=Tecentriq Hybreza
URL to AS/GPF Questionnaire endpoint (prod): https://prod-us-e1.apis.roche.com/pharma-cmg-ehr-fhir-exp-prod/v2/questionnaire?name=Tecentriq Hybreza
FDA approved indications (ICD10 codes) can be found on the Access Solutions website for Tecentriq Hybreza